TSX News -
Theratechnologies Partner Submits Biologics License Application for HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
MONTREAL, QUEBEC–(Marketwired – May 3, 2017) – Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that its partner, TaiMed Biologics, Inc., has […]